Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nano Labs (NA) Total Current Liabilities (2021 - 2025)

Nano Labs' Total Current Liabilities history spans 5 years, with the latest figure at $29.0 million for Q4 2025.

  • Quarterly results put Total Current Liabilities at $29.0 million for Q4 2025, changed 0.38% from a year ago — trailing twelve months through Dec 2025 was $29.0 million (changed 0.38% YoY), and the annual figure for FY2025 was $29.3 million, up 0.6%.
  • Total Current Liabilities for Q4 2025 was $29.0 million at Nano Labs, roughly flat from $29.2 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $145.8 million in Q4 2021 to a low of $25.8 million in Q4 2022.
  • The 5-year median for Total Current Liabilities is $29.2 million (2024), against an average of $52.7 million.
  • The sharpest move saw Total Current Liabilities plummeted 82.29% in 2022, then surged 30.48% in 2023.
  • Year by year, Total Current Liabilities stood at $145.8 million in 2021, then plummeted by 82.29% to $25.8 million in 2022, then skyrocketed by 30.48% to $33.7 million in 2023, then dropped by 13.46% to $29.2 million in 2024, then fell by 0.38% to $29.0 million in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $29.0 million, $29.2 million, and $33.7 million for Q4 2025, Q4 2024, and Q4 2023 respectively.